Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins
CA 1306961 C · Owner: Wadley Technologies, Inc. · Inventors: Berg, Kurt Frimann
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present inventions relate to production detection of, and characterization of monoclonal antibodies/hybridoma antibodies (and the corresponding hybridoma cells including derived hybrid cells) which are able to recognize proteins (or part(s) thereof) belonging antigenically to the Human Leukocyte Interferon System (HuIFN-.alpha.) - be the said proteins produced natively (for example by white blood cells) or produced by recombinant techniques (genetic engineering) or produced by peptide derivation of the said proteins or part(s) thereof) exhibiting the same common antigenic determinant(s) as found to be common in the native HuIFN-.alpha. system. Such antibodies (or the relevant part(s) …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 1, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 1, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.